R. Bradley  Gray net worth and biography

R. Gray Biography and Net Worth

R. Bradley Gray has served as a member of the board of directors and as President and Chief Executive Officer since June 2010. Prior to joining our company, Mr. Gray held various positions at Genzyme, a biotechnology company acquired by Sanofi in 2011. He served as Vice President of Product & Business Development for Genzyme Genetics, the diagnostic services division of Genzyme, from June 2008 to May 2010, leading the development of molecular diagnostics and partnering activities. From September 2006 to June 2008, he served as Vice President of Business & Strategic Development for Genzyme Genetics, leading growth efforts through partnerships and licensing. Mr. Gray joined Genzyme in October 2004 as Director of Corporate Development, supporting business development and leading Genzyme Ventures, the corporate venture capital fund of Genzyme. Prior to joining Genzyme, Mr. Gray was a management consultant in the healthcare practice of McKinsey & Company, a global management consulting firm, from September 2000 to October 2004, where he worked with senior healthcare executives in the United States and Europe on a broad range of issues including pharmaceutical and diagnostic product strategy, post-merger integration, organization design, and operational turnarounds. Mr. Gray received a B.A. in Economics and Management from Oxford University, where he studied as a British Marshall Scholar, and an S.B. in Chemical Engineering from the Massachusetts Institute of Technology.

What is R. Bradley Gray's net worth?

The estimated net worth of R. Bradley Gray is at least $0.00 as of May 25th, 2023. Mr. Gray owns 338,395 shares of NanoString Technologies stock worth more than $0 as of April 19th. This net worth approximation does not reflect any other assets that Mr. Gray may own. Additionally, Mr. Gray receives a salary of $1,060,000.00 as CEO at NanoString Technologies. Learn More about R. Bradley Gray's net worth.

How old is R. Bradley Gray?

Mr. Gray is currently 47 years old. There are 4 older executives and no younger executives at NanoString Technologies. Learn More on R. Bradley Gray's age.

What is R. Bradley Gray's salary?

As the CEO of NanoString Technologies, Inc., Mr. Gray earns $1,060,000.00 per year. Learn More on R. Bradley Gray's salary.

How do I contact R. Bradley Gray?

The corporate mailing address for Mr. Gray and other NanoString Technologies executives is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. NanoString Technologies can also be reached via phone at (888) 358-6266 and via email at [email protected]. Learn More on R. Bradley Gray's contact information.

Has R. Bradley Gray been buying or selling shares of NanoString Technologies?

R. Bradley Gray has not been actively trading shares of NanoString Technologies over the course of the past ninety days. Most recently, on Thursday, May 25th, R Bradley Gray bought 30,000 shares of NanoString Technologies stock. The stock was acquired at an average cost of $5.80 per share, with a total value of $174,000.00. Following the completion of the transaction, the chief executive officer now directly owns 338,395 shares of the company's stock, valued at $1,962,691. Learn More on R. Bradley Gray's trading history.

Who are NanoString Technologies' active insiders?

NanoString Technologies' insider roster includes K. Bailey (CFO), Joseph Beechem (SVP), Elisha Finney (Director), R. Gray (CEO), Robert Hershberg (Director), and Kirk Malloy (Director). Learn More on NanoString Technologies' active insiders.

Are insiders buying or selling shares of NanoString Technologies?

In the last year, NanoString Technologies insiders bought shares 3 times. They purchased a total of 80,400 shares worth more than $461,826.00. The most recent insider tranaction occured on May, 26th when CFO K Thomas Bailey bought 15,000 shares worth more than $86,400.00. Insiders at NanoString Technologies own 3.1% of the company. Learn More about insider trades at NanoString Technologies.

Information on this page was last updated on 5/26/2023.

R. Bradley Gray Insider Trading History at NanoString Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/25/2023Buy30,000$5.80$174,000.00338,395View SEC Filing Icon  
12/12/2022Buy62,500$7.35$459,375.00264,837View SEC Filing Icon  
3/15/2022Sell8,625$27.81$239,861.25View SEC Filing Icon  
3/8/2022Sell9,667$33.06$319,591.02View SEC Filing Icon  
11/10/2021Sell25,000$46.29$1,157,250.00View SEC Filing Icon  
5/12/2021Sell33,333$52.94$1,764,649.02189,743View SEC Filing Icon  
3/18/2021Sell21,684$65.96$1,430,276.64View SEC Filing Icon  
3/16/2021Sell5,179$66.32$343,471.28View SEC Filing Icon  
3/10/2021Sell33,333$62.04$2,067,979.32139,333View SEC Filing Icon  
1/20/2021Sell25,000$72.34$1,808,500.00111,486View SEC Filing Icon  
9/9/2020Sell37,951$38.85$1,474,396.35149,637View SEC Filing Icon  
7/6/2020Sell40,000$37.03$1,481,200.00142,903View SEC Filing Icon  
6/18/2020Sell6,363$33.57$213,605.91109,266View SEC Filing Icon  
2/14/2020Sell20,000$33.63$672,600.0070,050View SEC Filing Icon  
1/21/2020Sell20,000$29.99$599,800.0070,050View SEC Filing Icon  
8/12/2019Sell40,000$24.84$993,600.0089,905View SEC Filing Icon  
5/13/2019Sell50,000$26.59$1,329,500.0036,611View SEC Filing Icon  
3/14/2019Sell60,000$0.28$16,800.0077,130View SEC Filing Icon  
2/1/2019Sell20,000$22.28$445,600.00View SEC Filing Icon  
1/9/2019Sell30,000$20.04$601,200.00104,213View SEC Filing Icon  
4/3/2017Sell1,100$20.58$22,638.0075,785View SEC Filing Icon  
11/11/2016Sell37,325$22.49$839,439.2579,428View SEC Filing Icon  
See Full Table

R. Bradley Gray Buying and Selling Activity at NanoString Technologies

This chart shows R Bradley Gray's buying and selling at NanoString Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NanoString Technologies Company Overview

NanoString Technologies logo
NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.36
Low: $0.05
High: $0.80

2 Week Range

Now: N/A

Volume

23,061,200 shs

Average Volume

34,541,648 shs

Market Capitalization

$5.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24